Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
3,034,327
-
Shares change
-
+105,446
-
Total reported value, excl. options
-
$21,027,519
-
Value change
-
+$1,227,002
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$6.93
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2020
23 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q2 2020.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,034,327 shares
of 51,654,406 outstanding shares and own 5.9% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (750,000 shares), Stonepine Capital Management, LLC (668,430 shares), Granite Point Capital Management, L.P. (477,230 shares), Manatuck Hill Partners, LLC (351,100 shares), VANGUARD GROUP INC (241,817 shares), Corriente Advisors, LLC (201,248 shares), RENAISSANCE TECHNOLOGIES LLC (104,700 shares), NORTHERN TRUST CORP (95,871 shares), GEODE CAPITAL MANAGEMENT, LLC (56,412 shares), and BlackRock Inc. (44,508 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.